Turn Therapeutics Income Statement (2024-2026) | TTRX

Income Statement Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 0.15M0.01M0.01M0.16M0.03M0.11M
Wages, Salaries and Other (Quarter) 0.07M0.30M
Selling, General & Administrative (Quarter) 0.52M0.32M0.38M1.75M2.16M1.14M
Restructuring Costs (Quarter) 0.11M0.29M
Other Operating Expenses (Quarter) -0.11M-0.29M
Operating Expenses (Quarter) 0.67M0.33M0.38M1.91M2.19M1.25M
Operating Income (Quarter) -0.67M-0.33M-0.38M-1.91M-2.19M-1.25M
EBIT (Quarter) -0.67M-0.33M-0.38M-1.91M-2.19M-1.25M
Non-operating items
Non Operating Investment Income (Quarter) 0.70M
Interest & Investment Income (Quarter) 0.01M0.01M0.01M0.01M0.01M0.05M
Other Non Operating Income (Quarter) 0.05M0.00M0.01M
Non Operating Income (Quarter) 0.01M0.84M0.06M0.01M1.16M0.28M
Net income details
EBT (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Profit After Tax (Quarter) -0.67M-0.32M-0.33M-1.90M0.28M-0.97M
Income from Continuing Operations (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Consolidated Net Income (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Income towards Parent Company (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Net Income towards Common Stockholders (Quarter) -0.67M-0.32M-0.38M-1.91M-2.18M-1.20M
Additional items
EPS (Basic) (Quarter) -0.03-0.02-0.01-0.070.01-0.03
EPS (Weighted Average and Diluted) (Quarter) -0.03-0.02-0.01-0.070.01-0.03
Shares Outstanding (Weighted Average) (Quarter) 26.65M26.64M26.96M27.98M27.72M29.48M
Shares Outstanding (Diluted Average) (Quarter) 26.65M26.64M26.96M27.98M27.72M29.48M
EBITDA (Quarter) -0.67M-0.33M-0.38M-1.91M-2.19M-1.25M
Shares Outstanding (Quarter) 26.69M26.85M27.26M28.02M29.45M29.79M